Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > SP price Prediction

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson May 25, 2023 8:41am

347 Views

Post# 35463313

SP price Prediction

SP might recede today as some might opt to take some profit.

However, tomorrow there should be a straight line up, much higher because of ASCO reveal.

So, last chance to go in. This is really it. The make it higher moment for a penny stock worth biotech transforming itself into a PIII ready biotech.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"